Dr Suresh Gopala Pillai

Uwch Ddarlithydd - Meddygaeth frys

Biomedical Sciences

s.k.g.pillai@abertawe.ac.uk

005
Llawr Gwaelod
Y Sefydliad Gwyddor Bywyd 2
Campws Singleton

Ar gael ar gyfer Goruchwyliaeth Ôl-raddedig

Dolenni Ymchwil

https://orcid.org/0000-0002-9753-6949

Trosolwg

Derbyniodd Suresh gymhwyster Meddygaeth o Brifysgol Mysore, India yn 2000. Cwblhaodd ei hyfforddiant arbenigol mewn Meddygaeth Frys a Meddygaeth Gofal Dwys o Ddeoniaeth Cymru. Mae ei ddiddordeb ymchwil glinigol ym maes datblygu biofarcwyr mewn tolcheniad gwaed gan ddefnyddio technegau rheolegol. Enillodd ddyfarniad PhD ym Mhrifysgol Abertawe am archwilio effaith clefyd rhwystrol cronig yr ysgyfaint ar ficroadeiledd tolchen gwaed. Roedd Suresh yn rhan o sefydlu a datblygu Canolfan Ymchwil Meddygaeth Frys Cymru (WCEMR) sydd wedi'i lleoli yn Adran Achosion Brys Ysbyty Treforys.

Ar hyn o bryd, mae Suresh yn academydd clinigol sy'n gweithio fel meddyg ymgynghorol er anrhydedd mewn Meddygaeth Frys a Meddygaeth Gofal Dwys yn Ysbyty Treforys, Bwrdd Iechyd Prifysgol Bae Abertawe ac yn Uwch-ddarlithydd mewn Meddygaeth Frys (Ymchwil Uwch) ym Mhrifysgol Abertawe.

Meysydd Arbenigedd

Meddygaeth Frys
Meddygaeth Gofal Dwys
Tolcheniad gwaed
Haemoreholeg
Ymchwil drosi

Uchafbwyntiau Gyrfa

Prif Wobrau

2024: Y Coleg Brenhinol Meddygaeth Argyfwng (RCEM). Medal y Coleg yn 2024 am gyfraniad neilltuol at y Coleg Brenhinol Meddygaeth Argyfwng (RCEM), fel Is-lywydd RCEM Cymru

2020: Cynhadledd Ymchwil Ôl-raddedig Ysgol Feddygaeth Prifysgol Abertawe. Enillydd y crynodeb ar gyfer myfyrwyr yr ail flwyddyn ‘Fractal Dimension as a Biomarker of Thrombogenicity in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)’

2014: Cyfarfod Rhanbarthol Ysgol Meddygaeth Frys Cymru Gyfan. Y wobr gyntaf am gyflwyniad poster 'Predicting outcomes after blunt chest wall trauma: development and external validation of a new prognostic model’

2011: Cyfarfod Rhanbarthol Ysgol Meddygaeth Frys Cymru Gyfan. Cymeradwyaeth uchel ar gyfer cyflwyniad llafar y diwrnod ar gyfer cyflwyniad ar achos - ‘SVC obstruction’

Cydweithrediadau

Cyhoeddiadau

Uchafbwyntiau Ymchwil

Evans, V., Lawrence, M., Whitley, J., Johns, C., Gopala Pillai, S., Hawkins, K., Power, K., Morris, K., Williams, R., & Evans, A. (2022). The treatment effect of rivaroxaban on clot characteristics in patients who present acutely with first time deep vein thrombosis. Clinical Hemorheology and Microcirculation, 80(2), 139-151.
https://doi.org/10.3233/ch-201030, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa56606
Lawrence, M., Evans, V., Whitley, J., Gopala Pillai, S., Williams, R., Coulson, J., Krishnan, M., Slade, P., Power, K., Morris, R., & Evans, A. (2022). The effects of apixaban on clot characteristics in atrial fibrillation: A novel pharmacodynamic biomarker. Pharmacology Research and Perspectives, 10(2)
https://doi.org/10.1002/prp2.937, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa60554
Watson, O., Gopala Pillai, S., Howard, M., Zaldua, J., Whitley, J., Burgess, B., Lawrence, M., Hawkins, K., Morris, K., & Evans, A. (2022). Impaired fibrinolysis in severe Covid-19 infection is detectable in early stages of the disease. Clinical Hemorheology and Microcirculation, 82(2), 183-191.
https://doi.org/10.3233/ch-221491, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa61002
https://pubmed.ncbi.nlm.nih.gov/35694917/
Watson, O., ZALDUA, J., Gopala Pillai, S., Whitley, J., Howard, M., Lawrence, M., Hawkins, K., Morris, K., & Evans, A. (2023). The efficacy of low molecular weight heparin is reduced in Covid-19. Clinical Hemorheology and Microcirculation, 84(3), 1-12.
https://doi.org/10.3233/ch-221635, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa63235
http://dx.doi.org/10.3233/ch-221635
Lawrence, M., Obaid, D., Sabra, A., Whitley, J., Whitley, J., Quarry, R., Gopala Pillai, S., Chase, A., Smith, D., Williams, R., Hawkins, K., Morris, R., & Evans, A. (2023). The Impact of Patient Characteristics and Antiplatelet Regimes on Clot Microstructure in Patients Treated for ST Elevation Myocardial Infarction: Clot Microstructure can Evaluate Therapeutic Efficacy. Clinical and Applied Thrombosis/Hemostasis, 29, 107602962211315
https://doi.org/10.1177/10760296221131563, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa63236
http://dx.doi.org/10.1177/10760296221131563
Gopala Pillai, S., Butcher, L., Carnicero, J., Hawkins, K., Whitley, J., Mothukuri, R., Morris, K., Erusalimsky, J., & Evans, A. (2023). The biomarkers sRAGE and df in combination are significant predictors of mortality in COVID‑19 patients. Critical Care, 27(S1), P137
https://doi.org/10.1186/s13054-023-04377-x, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65237
Gopala Pillai, S., Zaldua, J., Watson, O., Howard, M., Lawrence, M., Whitley, J., Hawkins, K., Morris, K., & Evans, A. (2023). Low FEV1 is associated with increased mortality in acute exacerbation of COPD (AECOPD) in one year. Critical Care, 27(S1)
https://doi.org/10.1186/s13054-023-04377-x, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65238
Gopala Pillai, S., Watson, O., Howard, M., Whitley, J., Hawkins, K., Morris, K., & Evans, A. (2023). Does clot microstructure (df) predict mortality in acute exacerbation of chronic obstructive pulmonary disease (AECOPD)?. Critical Care, 27(S1), 107-108.
https://doi.org/10.1186/s13054-023-04377-x, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65239
Howard, M., Watson, O., Zaldua, J., Gopala Pillai, S., Whitley, J., Lawrence, M., Hawkins, K., Guy, O., & Evans, A. (2022). NEWS2 predicts severity of underlying inflammatory response and outcome in COVID-19 patients. In Critical Care (pp. 25-26). Springer Science and Business Media LLC.
https://doi.org/10.1186/s13054-022-03927-z, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65240
http://dx.doi.org/10.1186/s13054-022-03927-z
Gopala Pillai, S., Zaldua, J., Whitley, J., Watson, O., Howard, M., Hawkins, K., Morris, K., & Evans, A. (2022). The relationship between the procalcitonin levels and clot microstructure in acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Critical Care, 26(S1), 26-26.
https://doi.org/10.1186/s13054-022-03927-z, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65241
Gopala Pillai, S., Zaldua, J., Lawrence, M., Whitley, J., Watson, O., Harrison, K., Hawkins, K., Morris, K., & Evans, A. (2022). Clot microstructure (df) as a biomarker and measurement of thrombogenicity in acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Critical Care, 26(S1), 28-28.
https://doi.org/10.1186/s13054-022-03927-z, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65242
Watson, O., Howard, M., Zaldua, J., Whitley, J., Gopala Pillai, S., Lawrence, M., Burgess, B., Hawkins, K., Morris, K., & Evans, A. (2022). Impaired fibrinolysis is implicated in mortality in COVID‑19 infection. In Critical Care (pp. 31-31). Springer Science and Business Media LLC.
https://doi.org/10.1186/s13054-022-03927-z, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65244
http://dx.doi.org/10.1186/s13054-022-03927-z

Holl Ymchwil

Erthyglau Cylchgronau

Watson, O., ZALDUA, J., Gopala Pillai, S., Whitley, J., Howard, M., Lawrence, M., Hawkins, K., Morris, K., & Evans, A. (2023). The efficacy of low molecular weight heparin is reduced in Covid-19. Clinical Hemorheology and Microcirculation, 84(3), 1-12.
https://doi.org/10.3233/ch-221635, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa63235
http://dx.doi.org/10.3233/ch-221635
Gopala Pillai, S., Butcher, L., Carnicero, J., Hawkins, K., Whitley, J., Mothukuri, R., Morris, K., Erusalimsky, J., & Evans, A. (2023). The biomarkers sRAGE and df in combination are significant predictors of mortality in COVID‑19 patients. Critical Care, 27(S1), P137
https://doi.org/10.1186/s13054-023-04377-x, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65237
Gopala Pillai, S., Zaldua, J., Watson, O., Howard, M., Lawrence, M., Whitley, J., Hawkins, K., Morris, K., & Evans, A. (2023). Low FEV1 is associated with increased mortality in acute exacerbation of COPD (AECOPD) in one year. Critical Care, 27(S1)
https://doi.org/10.1186/s13054-023-04377-x, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65238
Gopala Pillai, S., Watson, O., Howard, M., Whitley, J., Hawkins, K., Morris, K., & Evans, A. (2023). Does clot microstructure (df) predict mortality in acute exacerbation of chronic obstructive pulmonary disease (AECOPD)?. Critical Care, 27(S1), 107-108.
https://doi.org/10.1186/s13054-023-04377-x, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65239
Lawrence, M., Obaid, D., Sabra, A., Whitley, J., Whitley, J., Quarry, R., Gopala Pillai, S., Chase, A., Smith, D., Williams, R., Hawkins, K., Morris, R., & Evans, A. (2023). The Impact of Patient Characteristics and Antiplatelet Regimes on Clot Microstructure in Patients Treated for ST Elevation Myocardial Infarction: Clot Microstructure can Evaluate Therapeutic Efficacy. Clinical and Applied Thrombosis/Hemostasis, 29, 107602962211315
https://doi.org/10.1177/10760296221131563, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa63236
http://dx.doi.org/10.1177/10760296221131563
Watson, O., Gopala Pillai, S., Howard, M., Zaldua, J., Whitley, J., Burgess, B., Lawrence, M., Hawkins, K., Morris, K., & Evans, A. (2022). Impaired fibrinolysis in severe Covid-19 infection is detectable in early stages of the disease. Clinical Hemorheology and Microcirculation, 82(2), 183-191.
https://doi.org/10.3233/ch-221491, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa61002
https://pubmed.ncbi.nlm.nih.gov/35694917/
Lawrence, M., Evans, V., Whitley, J., Gopala Pillai, S., Williams, R., Coulson, J., Krishnan, M., Slade, P., Power, K., Morris, R., & Evans, A. (2022). The effects of apixaban on clot characteristics in atrial fibrillation: A novel pharmacodynamic biomarker. Pharmacology Research and Perspectives, 10(2)
https://doi.org/10.1002/prp2.937, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa60554
Gopala Pillai, S., Zaldua, J., Whitley, J., Watson, O., Howard, M., Hawkins, K., Morris, K., & Evans, A. (2022). The relationship between the procalcitonin levels and clot microstructure in acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Critical Care, 26(S1), 26-26.
https://doi.org/10.1186/s13054-022-03927-z, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65241
Gopala Pillai, S., Zaldua, J., Lawrence, M., Whitley, J., Watson, O., Harrison, K., Hawkins, K., Morris, K., & Evans, A. (2022). Clot microstructure (df) as a biomarker and measurement of thrombogenicity in acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Critical Care, 26(S1), 28-28.
https://doi.org/10.1186/s13054-022-03927-z, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65242
Evans, V., Lawrence, M., Whitley, J., Johns, C., Gopala Pillai, S., Hawkins, K., Power, K., Morris, K., Williams, R., & Evans, A. (2022). The treatment effect of rivaroxaban on clot characteristics in patients who present acutely with first time deep vein thrombosis. Clinical Hemorheology and Microcirculation, 80(2), 139-151.
https://doi.org/10.3233/ch-201030, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa56606

Cyfraniadau Cynadleddau

Howard, M., Watson, O., Zaldua, J., Gopala Pillai, S., Whitley, J., Lawrence, M., Hawkins, K., Guy, O., & Evans, A. (2022). NEWS2 predicts severity of underlying inflammatory response and outcome in COVID-19 patients. In Critical Care (pp. 25-26). Springer Science and Business Media LLC.
https://doi.org/10.1186/s13054-022-03927-z, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65240
http://dx.doi.org/10.1186/s13054-022-03927-z
Watson, O., Howard, M., Zaldua, J., Whitley, J., Gopala Pillai, S., Lawrence, M., Burgess, B., Hawkins, K., Morris, K., & Evans, A. (2022). Impaired fibrinolysis is implicated in mortality in COVID‑19 infection. In Critical Care (pp. 31-31). Springer Science and Business Media LLC.
https://doi.org/10.1186/s13054-022-03927-z, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65244
http://dx.doi.org/10.1186/s13054-022-03927-z